![]() |
Online Slide/Audio Symposium |
![]() |
Opening Remarks: Development of the NKF-DOQI Guidelines
Garabed Eknoyan, M.D. ![]() Changing Clinical Practice Through Evidence and Experience: DOQI targets for anemia. Joseph W. Eschbach, M.D., Program Chairperson ![]() Iron, Ferritin, and Infection: Cause or Effect? John W. Adamson, M.D. ![]() Elevated Iron Indices vs. Iron Overload: Role of Monitoring and Surveillance John C. Stivelman, M.D. ![]() Subcutaneous rHuEPO administration: What is the controversy? Jeffrey S. Berns, M.D. ![]() Applying the Anemia Guidelines: Risk/Benefit Analysis Jay B. Wish, M.D. ![]() Questions and Answers Drs. Eschbach, Adamson, Stivelman, Berns, and Wish ![]() Comments, new questions, and opinions General comments regarding anemia guidelines |
Faculty |
John W. Adamson, M.D.,
Director of Research, Lindsley F. Kimbal Research Institute, New York Blood
Center, New York, NY
![]() Jeffrey S. Berns, M.D., Clinical Associate Professor of Medicine, Allegheny University Hospital, Graduate, Philadelphia, PA ![]() Garabed Eknoyan, M.D., Professor of Medicine, Baylor College of Medicine, Houston, TX; President, National Kidney Foundation, NKF-DOQI Co-Chair ![]() Joseph Eschbach, M.D., Chair, Clinical Professor of Medicine, University of Washington Minor and James Medical, Seattle, WA ![]() John C. Stivelman, M.D., Associate Professor of Medicine, Emory University Medical Center, Atlanta, GA ![]() Jay B. Wish, M.D., Professor of Medicine, Case Western University, Medical Director, Hemodialysis Unit, University Hospitals of Cleveland, Cleveland, OH |
Back to symposia list by topic
Back to symposia list by meeting
Back to HDCN home page